NCT00777361View on ClinicalTrials.gov

Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Alzheimer's Disease

Interventions

DRUG

AZD3480

Iv single dose, 4-hour infusion of 25 mg

DRUG

AZD3480

Oral solution single dose of 50 mg

Trial Locations (1)

Unknown

Research site, Macclesfield

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY